# Trade Mark Journal No.2025/051 19 December 2025

## WO0000001890494 (10)

Office of origin: United States of America

Date of International Registration:31 October 2025
Date of designation in the UK: 31 October 2025

Registration of this mark shall give no right to the exclusive use of the word medical.

International priority date claimed: 2 May 2025 (United States of America) (99167529)

Class 10
  Selective cytopheretic devices, namely medical devices used to treat conditions caused by a dysregulated immune response by selectively binding certain activated white blood cells, reducing their inflammatory state, and releasing the modified blood cells back into the blood.

SeaStar Medical, Inc.

Representative: Carla B. Oakley Morgan, Lewis & Bockius LLP, One Market, Spear Street Tower, San Francisco CA 94105, UNITED STATES OF AMERICA